Fonar Corporation  

(Public, NASDAQ:FONR)   Watch this stock  
Find more results for FONR
+0.53 (3.51%)
Oct 9 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 15.05 - 15.75
52 week 9.10 - 15.75
Open 15.13
Vol / Avg. 79,050.00/46,107.00
Mkt cap 97.27M
P/E 8.11
Div/yield     -
EPS 1.93
Shares 6.05M
Beta 1.47
Inst. own 20%
Nov 9, 2015
Q1 2016 Fonar Corp Earnings Release (Estimated) Add to calendar
Sep 14, 2015
Q4 2015 Fonar Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '15) 2015
Net profit margin 36.74% 22.35%
Operating margin 18.94% 19.25%
EBITD margin - 23.81%
Return on average assets 32.93% 20.13%
Return on average equity 60.16% 37.90%
Employees 465 -
CDP Score - -


110 Marcus Dr
MELVILLE, NY 11747-4228
United States - Map
+1-631-6942929 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Fonar Corporation (Fonar) operates in two segments: medical equipment segment, conducted directly through Fonar and physician management and diagnostic services segment, conducted through its subsidiary Health Management Corporation of America (HMCA). The Company is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions and injuries. HMCA provides management services, administrative services, billing and collection services, office space, equipment, repair, maintenance service and clerical and other non-medical personnel to medical providers. The Company’s products include Upright MRI, a whole body open MRI system that enables positional MRI applications and the Fonar 360, an enlarged room sized magnet in which the floor, ceiling and walls of the scan room are part of the magnet frame.

Officers and directors

Raymond V Damadian Chairman of the Board, President, Chief Executive Officer, Treasurer
Age: 78
Bio & Compensation  - Reuters
Claudette J. V. Chan Secretary, Director
Age: 76
Bio & Compensation  - Reuters
Charles N. O'Data Lead Independent Director
Age: 78
Bio & Compensation  - Reuters
Robert J Janoff Independent Director
Age: 87
Bio & Compensation  - Reuters
Ronald G. Lehman Independent Director
Age: 38
Bio & Compensation  - Reuters